Funded Grants

Substance use during pregnancy can have negative effects on infants, including congenital disabilities, delayed neurodevelopment, and long-term learning difficulties.

This proposal is based on our finding of substantial depletion of neurofilament synthesis in mouse models of ALS with abnormal accumulations of TDP-43, a hallmark of the disease.

In Canada, the annual cost to care for individuals with neurodegenerative diseases is over $10.4 billion.

Amyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset.

In everyday life, we are solicited by numerous stimulations coming from different sensory modalities (e.g., visual, tactile, auditory…).

Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease and the fastest growing neurodegenerative disorder worldwide.

This research is motivated by the Canadian Dementia Strategy priority and urgent need to “build the evidence base to inform and promote the adoption of effective interventions” for dementia prevention.

Memory is a fundamental aspect of human cognition that allows us to remember past experiences that shape our future actions.

We are working on an innovative project to improve speech therapy for children who have trouble speaking or understanding language.

Canada has one of the world’s highest rates of multiple sclerosis (MS), a disease that can lead to significant disability.